Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
MDLN · against 63 other Healthcare companies of similar size
Ranked #52 of 64 · scores higher than 19% of peers · safety percentile 21
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)16 peers with a safety percentile of 20–29, including MDLN · Click a bar to see the companies
Mainly because of its debt / equity, which is weaker than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | MDLN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 60 reported | 0.66× | 0.50× | 36% | 33% | |
| BetaLower is better · 61 reported | Not reported | 0.74 | — | — | 33% |
| Current ratioHigher is better · 61 reported | 4.33× | 1.80× | 83% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 26.0B USD | 93 | 28 | |
| 2 | 327.3B CNY (≈$45.8B) | 92 | 75 | |
| 3 | 56.7B USD | 85 | 79 | |
| 4 | 8.24T JPY (≈$56.0B) | 83 | 75 | |
| 5 | 25.8B USD | 83 | 75 | |
| 48 | 52.9B USD | 23 | 57 | |
| 49 | 21.7B EUR (≈$23.9B) | 22 | 47 | |
| 50 | 27.8B USD | 22 | 55 | |
| 51 | 48.5B EUR (≈$53.4B) | 21 | 53 | |
| 52 | 45.9B USD | 21 | 61 | |
| 53 | 31.3B USD | 20 | 63 | |
| 54 | 66.3B USD | 20 | 30 | |
| 55 | 33.3B USD | 19 | 24 | |
| 56 | 36.4B USD | 19 | 50 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score